Wells Fargo Maintains Overweight on Eli Lilly, Raises Price Target to $650
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Mohit Bansal maintains an Overweight rating on Eli Lilly (NYSE:LLY) and raises the price target from $615 to $650.
October 09, 2023 | 11:50 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo maintains an Overweight rating on Eli Lilly and raises the price target from $615 to $650, which could positively impact the stock's price.
The raised price target by Wells Fargo indicates a positive outlook for Eli Lilly. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100